African Americans (AA) Communities Speak

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity of Alabama at Birmingham

About this trial

African Americans are less likely to receive quality end-of-life (EoL) care. Addressing disparities in EoL care will need efforts to support a better understanding of African American patients' EoL cultural values and preferences for EoL communication and the impact of historical and ongoing care delivery inequities in healthcare settings.

Our proposed "Caring for Older African Americans" training program is designed to empower clinicians to improve goal-concordant EoL care delivery by using community-developed storytelling videos to create empathy with experiences of racism in EoL care, guidelines for culturally concordant EoL care delivery, and an implicit bias recognition and management training to mitigate bias in goals of care communication.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Self-identified as African American (i.e., born, raised, and lived primarily in the US)

Non-Hispanic or Latino

Age ≥60 years

English-speaking

Disqualifiers

Self-identified as African American (i.e., born, raised, and lived primarily in the US)

Non-Hispanic or Latino

Age ≥60 years

English-speaking

Trial design

Design model

Parallel

Treatments tested in this trial

  • AA Communities Speak to Healthcare Professionals

    Behavioral

    The training program is designed to empower clinicians to improve goal-concordant EoL care delivery by using community-developed storytelling videos to create empathy with experiences of racism in EoL care, guidelines for culturally concordant EoL care delivery, and implicit bias recognition and management training to mitigate bias in goals of care communication.

Treatment groups

60 Participants
are divided into 4 treatment groups
Group A: Clinician Trainees- Cluster 1Other 1 intervention
Group B: Clinician Trainees- Cluster 2Other 1 intervention
Group C: Clinician Trainees- Cluster 3Other 1 intervention
Group D: Clinician Trainees- Cluster 4Other 1 intervention

Trial outcomes

Primary outcomes

1

Human Connection Scale (patient/family reported)

The Human Connection (THC) Scale is a summary score of item responses such that a higher total score indicates greater therapeutic alliance. Possible scores range from 16 to 64. The 16-item THC scale had a high degree of internal consistency (Cronbach α= 90).

Time frame
up to 3 months before the intervention
2

Human Connection Scale (patient/ family reported)

The Human Connection (THC) Scale is a summary score of item responses such that a higher total score indicates greater therapeutic alliance. Possible scores range from 16 to 64. The 16-item THC scale had a high degree of internal consistency (Cronbach α= 90).

Time frame
up to 3 months after intervention

Secondary outcomes

1

Goal Concordant Care (patient/family reported)

Goal Concordant Care will be measured based on responses to the following two questions, each with a dichotomous outcome: 1. Family member reports that the patient's end-of-life wishes were adequately discussed with the family respondent 2. Family member's satisfaction that patient's end-of-life were met. Johnson, S.B., Butow, P.N., Bell, M.L. et al. A randomized controlled trial of an advance care planning intervention for patients with incurable cancer. Br J Cancer 119, 1182-1190 (2018). https://doi.org.10.1038/s41416-018-0303-7

Time frame
up to 3 months before the intervention
2

Goal Concordant Care (patient/family reported)

Goal Concordant Care will be measured based on responses to the following two questions, each with a dichotomous outcome: 1. Family member reports that the patient's end-of-life wishes were adequately discussed with the family respondent 2. Family member's satisfaction that patient's end-of-life were met. Johnson, S.B., Butow, P.N., Bell, M.L. et al. A randomized controlled trial of an advance care planning intervention for patients with incurable cancer. Br J Cancer 119, 1182-1190 (2018). https://doi.org.10.1038/s41416-018-0303-7

Time frame
up to 3 months after the intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Alabama at Birmingham

Lead sponsor

Montefiore Medical Center

Collaborator

University of Massachusetts, Worcester

Collaborator

National Institute on Aging (NIA)

Collaborator

Hospice of Henderson County, Inc.

Collaborator